Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03790488
Title Study of a PD-1 Inhibitor (JTX-4014) in Subjects With Solid Tumor Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Jounce Therapeutics, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Sarah Cannon Research Institute at HealthONE Denver Colorado 80218 United States Details
Florida Cancer Specialists - Sarasota Cattlemen Sarasota Florida 34232 United States Details
START Midwest - Cancer & Hematology Centers of Western Michigan Grand Rapids Michigan 49546 United States Details
South Texas Accelerated Research Therapeutics (START) San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field